AnalystsMatthew CaufieldMatthew Caufield's Stock Forecasts
AnalystsMatthew Caufield
Analyst Ranking
Top 10%
#485 out of 5209 analysts
Average Return
+11.46%
Win Rate
45%77 out of 172
Risk vs Reward
Poor
Good
Matthew Caufield's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Opus Genetics IncIRD | +402.20% | $0.91 | $4.57 | 2025-04-01 - 2026-03-04 | Buy |
Opus Genetics IncIRD | +367.76% | $0.98 | $4.57 | 2025-06-27 - 2026-03-04 | Buy |
Phathom Pharmaceuticals IncPHAT | +300.72% | $2.76 | $11.06 | 2025-05-02 - 2026-03-04 | Buy |
Zenas Biopharma IncZBIO | +271.61% | $8.77 | $32.59 | 2024-12-16 - 2025-12-15 | Buy |
Surrozen IncSRZN | +256.75% | $8.00 | $28.54 | 2025-05-12 - 2026-03-04 | Buy |
Matthew Caufield Analyst Color
Get additional color on Matthew Caufield's coverage of popular stocks
Matthew Caufield's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunic IncIMUX | 8 | Buy | $5.00 | +327.35% | Maintains | 4 days ago |
Fibrobiologics IncFBLG | 9 | Buy | $4.00 | +963.83% | Maintains | 8 days ago |
Ardelyx IncARDX | 2 | Buy | $18.00 | +170.68% | Maintains | 14 days ago |
Zenas Biopharma IncZBIO | 5 | Buy | $44.00 | +70.41% | Reiterates | 24 days ago |
Kodiak Sciences IncKOD | 9 | Buy | $38.00 | +41.58% | Reiterates | 24 days ago |
Akebia Therapeutics IncAKBA | 4 | Buy | $6.00 | +380.00% | Reiterates | a month ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $5.00 | +14.68% | Downgrades | 4 months ago |
Mineralys Therapeutics IncMLYS | 13 | Buy | $56.00 | +94.65% | Maintains | 4 months ago |
Phathom Pharmaceuticals IncPHAT | 11 | Buy | $26.00 | +135.08% | Maintains | 4 months ago |
Tarsus Pharmaceuticals IncTARS | 2 | Buy | $88.00 | +15.49% | Maintains | 4 months ago |
Diamedica Therapeutics IncDMAC | 7 | Buy | $12.00 | +54.44% | Reiterates | 7 months ago |
Lyra Therapeutics IncLYRA | 8 | Hold | $16.00 | +1,169.84% | Reiterates | 7 months ago |
Lenz Therapeutics IncLENZ | 7 | Buy | $56.00 | +332.10% | Maintains | 7 months ago |
Opus Genetics IncIRD | 13 | Buy | $8.00 | +75.05% | Reiterates | 8 months ago |
Unity Biotechnology IncUNBX | 9 | Hold | $2.00 | +900.00% | Downgrades | 9 months ago |
Optinose IncOPTN | 8 | Hold | $9.00 | -6.25% | Reiterates | 10 months ago |
Aldeyra Therapeutics IncALDX | 13 | Buy | $10.00 | +92.49% | Reiterates | 10 months ago |
Surrozen IncSRZN | 3 | Buy | $32.00 | +12.12% | Reiterates | 10 months ago |
Hillevax IncHLVX | 5 | Hold | $2.00 | -4.31% | Reiterates | a year ago |
Opthea LtdOPTEY | 7 | Hold | $2.00 | -41.35% | Downgrades | a year ago |
Hyperion Defi IncHYPD | 16 | Hold | $2.00 | -37.69% | Reiterates | a year ago |
4d Molecular Therapeutics IncFDMT | 18 | Buy | $36.00 | N/A | Reiterates | a year ago |
FabrinetFN | 1 | Buy | $28.00 | N/A | Reiterates | 3 years ago |
Iveric Bio IncISEE | 6 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Oyster Point Pharma IncOYST | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.